Serum progastrin-releasing peptide in pneumonia, chronic obstructive pulmonary disease and early-stage primary lung cancers
2023

Serum progastrin-releasing peptide in pneumonia, COPD, and early-stage lung cancers

Sample size: 198 publication Evidence: moderate

Author Information

Author(s): Begolli Gramos, Lukić Maja, Rumora Lada, Čorak Lorna, Vukić Dugac Andrea, Jakopović Marko, Samaržija Miroslav, Tomaš Ilijan, Knežević Jelena, Debeljak Željko

Primary Institution: University Hospital Centre Zagreb

Hypothesis

The study aims to compare serum proGRP concentration in pneumonia, chronic obstructive pulmonary disease (COPD), and early-stage primary lung cancers.

Conclusion

ProGRP concentrations in pneumonia and COPD patients were higher than in early-stage lung cancer patients.

Supporting Evidence

  • Median proGRP > 50 ng/L was measured in pneumonia and COPD.
  • Median proGRP < 40 ng/L was measured in early-stage lung adenocarcinoma and squamous cell carcinoma.
  • ProGRP concentrations were associated with CRP levels.
  • ProGRP levels in pneumonia and COPD may exceed those in early-stage small-cell lung cancer.

Takeaway

This study found that patients with pneumonia and COPD have higher levels of a specific protein in their blood compared to those with early-stage lung cancer.

Methodology

An observational study comparing serum proGRP concentrations among patients with pneumonia, COPD, and early-stage lung cancers.

Potential Biases

The study design may limit the generalizability of the findings due to the specific patient population.

Limitations

The sample size is relatively low, and other causes of elevated serum proGRP were not analyzed.

Participant Demographics

{"age":{"pneumonia":"70 (47-90)","lung_cancer":"63 (43-78)"},"gender":{"male":{"pneumonia":67,"lung_cancer":78},"female":{"pneumonia":24,"lung_cancer":29}},"smoking_status":{"smoker":{"pneumonia":61,"lung_cancer":73},"non_smoker":{"pneumonia":28,"lung_cancer":34}}}

Statistical Information

P-Value

< 0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.11613/BM.2025.010702

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication